© 2017 CIVA. All rights reserved. a LIFT creation
Dr. Berk is a graduate of the University of the Witwatersrand in Johannesburg, South Africa. He received his training in internal medicine and cardiology in South Africa under Dr. John Barlow and completed a cardiology fellowship at the University of Kentucky in Lexington, Kentucky. Dr. Berk worked with Dr. Anthony DeMaria on the cardiology faculty at the University of Kentucky for five years, and was the Director of the Heart Failure Program. He also served as one of the principal investigators of the National Heart, Lung, and Blood Institute balloon valvuloplasty registry.
Dr. Berk is board certified in cardiovascular disease and internal medicine. He is a fellow of the American College of Chest Physicians and of the American Heart Association. He is a member of the American Society of Echocardiography and on the Clinical Cardiology Council of the American Heart Association. He has published numerous manuscripts and more than 50 abstracts dealing with his interest in congestive heart failure, echocardiography, valvular heart disease, and atrial fibrillation.
Dr. Berk performs a full range of invasive and noninvasive cardiac procedures, including cardiac catheterization, balloon valvuloplasty, endomyocardial biopsy, and transesophageal echocardiography.
Dr. Berk is director of the Cardiovascular Research Institute of Dallas, affiliated with CIVA, and has been and is the principal investigator on many important heart failure, hypertension, and atrial fibrillation research studies. These studies, such as Merit, PRAISE, PROMISE, LIFE, as well as studies with Dofetilide (Tikosyn) and Sotalol, to name but a few, have fundamentally changed the treatment of heart disease over the past 15 years.